Northeast Financial Consultants’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6K | Hold |
63,351
| – | – | ﹤0.01% | 298 |
|
|
2025
Q1 | $26.7K | Buy |
63,351
+38,851
| +159% | +$16.3K | ﹤0.01% | 275 |
|
|
2024
Q4 | $17.2K | Hold |
24,500
| – | – | ﹤0.01% | 286 |
|
|
2024
Q3 | $11.5K | Hold |
24,500
| – | – | ﹤0.01% | 294 |
|
|
2024
Q2 | $40.7K | Hold |
24,500
| – | – | ﹤0.01% | 269 |
|
|
2024
Q1 | $44.6K | Hold |
24,500
| – | – | ﹤0.01% | 286 |
|
|
2023
Q4 | $45.3K | Hold |
24,500
| – | – | ﹤0.01% | 277 |
|
|
2023
Q3 | $35.3K | Hold |
24,500
| – | – | ﹤0.01% | 282 |
|
|
2023
Q2 | $44.8K | Hold |
24,500
| – | – | ﹤0.01% | 284 |
|
|
2023
Q1 | $48.5K | Hold |
24,500
| – | – | ﹤0.01% | 312 |
|
|
2022
Q4 | $51.5K | Buy |
+24,500
| New | +$51.5K | ﹤0.01% | 318 |
|